Discover the crucial differences between pro forma and GAAP financial statements. Learn why companies use both and the ...

AngioDynamics, Inc. ANGO reported breakeven adjusted earnings per share for second-quarter fiscal 2026, marking an ...

2025 Guidance: Q4 2025 revenue expected to exceed $4.5 million, representing ~100% year-over-year growth versus Q4 2024. Full ...

Critical Metals Corp. ( CRML) is on a rollercoaster ride. Since rumors surfaced that the U.S. would take an equity stake in ...

On October 17, 2025, RedHill Biopharma completed a strategic transaction with Cumberland Pharmaceuticals involving Talicia®, its proprietary drug, by selling a 30% equity stake in newly formed Talicia ...

SKYWAY (NCT07148414) is a Phase 2 basket trial of SPY072 (anti-TL1A) in patients with moderate to severely active RA, PsA, or axSpA. Enrollment is on track, and all indications are expected to readout ...

Piedmont Augusta names CFO Nikki McLain to lead financial operations and strategic growth for its Augusta clinical hub.

The South Carolina Small Business Development Center will offer a series of workshops and webinars in January and February designed to help entrepreneurs start businesses, strengthen business plans, p ...

CYB003/CYB004 clinical catalysts into 2026, $248M cash runway, equity raises risk, valuation optionality. Click for this CYBN update.

Two NDA submissions expected by mid-February 2026 for ulixacaltamide in essential tremor and relutrigine in SCN2A/8A-DEEs, both with Breakthrough ...

In community development, progress is rarely linear. There are moments when the spreadsheets work but the timing doesn’t.